Fully embrace new media and expand sales channels

Release time:

Sep 01,2020

With the rapid development of the information era, the marketing pattern of traditional offline channels has undergone profound changes under the impact of new media. Against this backdrop of development, Peptide Pharmaceuticals has further strengthened its confidence in development, focusing on private domain traffic to build a "micro-ecological chain" system. The New Media Sales Department was officially established on September 1, 2020. 

At present, the New Media Sales Department is sorting out the positioning of the company, understanding its long-term development goals, and producing high-quality personal health products related to the company's brand. By ensuring the continuous output of high-quality product content on various new media platforms, effective traffic is continuously introduced, attracting valuable users, and achieving stable monetization on various new media platforms, the ultimate goal is to expand the breadth and depth of customers' understanding of the corporate brand. We have effectively promoted the integration of online and offline development, comprehensively promoted the diversification of new channels, and constructed a three-dimensional new media marketing model. Peptide Pharmaceuticals will continue to adhere to the values and concepts of "innovation, realism, integrity, and agility", continuously innovate models to lead the transformation and upgrading of marketing methods, gather the strength of the enterprise's upward and downward progress, and write a new chapter of Peptide with a new brush!

Warmly celebrate the establishment of Jiangsu Putai Pharmaceutical Technology Co., Ltd. Release time: Jul 14, 2020 
On July 14, 2020, to better accelerate the pace of enterprise new drug research and development and meet the increasing market demand for personal health products, Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. (hereinafter referred to as Jiangsu Pulai) officially registered and established Jiangsu Pulai Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Jiangsu Pulai). After the establishment of Jiangsu Peptide, it will improve the company's innovative products, management level, and marketing strategy in response to the current market demand for personal care and health products from customers, further integrate resources, improve the response speed to customer needs, and make greater contributions to the development of the group business belonging to Jiangsu Peptide.